Advancing solid-state batteries towards commercial reality

Ilika Plc

Ilika plc is positioning itself as a European contender in the race to commercialise solid-state batteries, a technology widely regarded as a potential successor to conventional lithium-ion systems.

Solid-state batteries replace liquid electrolytes with solid materials, aiming to improve safety, energy density and operational life.

The company operates a dual-platform model. Its Stereax range targets miniature, high-value applications such as medical implants and industrial sensing devices. These markets demand reliability, compact form factors and long service life, characteristics that align with solid-state design advantages.

At the larger end of the spectrum, Ilika is developing its Goliath cells for electric vehicle and high-energy applications. Automotive adoption represents a materially larger opportunity but also carries higher execution risk. Cell capacity scaling, consistency of output and compatibility with existing manufacturing processes are central hurdles. Ilika has moved to produce larger-format prototype cells on an automated pilot line, signalling progress from research to repeatable fabrication.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search